BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWI
3326
DELISTED
SolarWinds Corporation Common Stock
SWI
| $52.6K | ﹤0.01% |
2,702
+849
| +46% | +$16.1K |
|
3327
Heritage Insurance Holdings
HRTG
$989M
| $52.4K | ﹤0.01% |
3,508
-86
| -2% | -$1.25K |
|
3328
CytomX Therapeutics
CTMX
$730M
| $52.4K | ﹤0.01% |
7,094
+2,126
| +43% | +$21K |
|
3329
Funko
FNKO
$335M
| $52.2K | ﹤0.01% |
2,538
+1,222
| +93% | +$28.3K |
|
|
NETI
3330
DELISTED
Eneti Inc.
NETI
| $52K | ﹤0.01% |
921
+42
| +5% | +$2.36K |
|
3331
VirnetX Holding Corp
VHC
$64.8M
| $51.9K | ﹤0.01% |
480
+147
| +44% | +$17.5K |
|
3332
VanEck Vietnam ETF
VNM
$506M
| $51.8K | ﹤0.01% |
3,175
-3,275
| -51% | -$52.2K |
|
3333
NVE Corp
NVEC
$563M
| $51.5K | ﹤0.01% |
776
+201
| +35% | +$13.7K |
|
3334
Magna International
MGA
$18.7B
| $51.5K | ﹤0.01% |
965
+291
| +43% | +$14.5K |
|
3335
Amerant Bancorp
AMTB
$1.14B
| $51.3K | ﹤0.01% |
2,445
+1,512
| +162% | +$27.7K |
|
3336
Ameresco
AMRC
$1.47B
| $51.2K | ﹤0.01% |
3,188
-68
| -2% | -$992 |
|
|
BSTC
3337
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $51.1K | ﹤0.01% |
954
+302
| +46% | +$17.6K |
|
|
DPLO
3338
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $51K | ﹤0.01% |
10,405
-745
| -7% | -$4.17K |
|
|
GNMK
3339
DELISTED
GenMark Diagnostics, Inc
GNMK
| $51K | ﹤0.01% |
8,408
+2,274
| +37% | +$14.2K |
|
3340
Arbor Realty Trust
ABR
$981M
| $50.9K | ﹤0.01% |
3,885
-12,754
| -77% | -$159K |
|
3341
Motorcar Parts of America
MPAA
$235M
| $50.9K | ﹤0.01% |
3,012
-107
| -3% | -$1.79K |
|
|
CBAY
3342
DELISTED
Cymabay Therapeutics
CBAY
| $50.9K | ﹤0.01% |
9,933
+3,246
| +49% | +$19.7K |
|
3343
MediciNova
MNOV
$64.5M
| $50.8K | ﹤0.01% |
6,384
+1,943
| +44% | +$17.3K |
|
|
PS
3344
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $50.6K | ﹤0.01% |
3,012
-726,183
| -100% | -$15.6M |
|
3345
KRONOS Worldwide
KRO
$996M
| $50.6K | ﹤0.01% |
4,088
-95
| -2% | -$1.18K |
|
3346
Peoples Financial Services
PFIS
$717M
| $50.5K | ﹤0.01% |
1,116
+3
| +0.3% | +$135 |
|
3347
Citizens & Northern Corp
CZNC
$466M
| $50.5K | ﹤0.01% |
1,922
+38
| +2% | +$950 |
|
3348
BioCryst Pharmaceuticals
BCRX
$2.51B
| $50K | ﹤0.01% |
17,458
+5,197
| +42% | +$16.2K |
|
3349
Rigel Pharmaceuticals
RIGL
$762M
| $50K | ﹤0.01% |
2,675
+819
| +44% | +$16.9K |
|
|
CVRS
3350
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $49.8K | ﹤0.01% |
11,635
+11,396
| +4,768% | +$41.3K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.